CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $231,000 | -32.3% | 3,050 | 0.0% | 0.15% | -16.4% |
| Q3 2021 | $341,000 | -31.0% | 3,050 | 0.0% | 0.18% | -38.0% |
| Q2 2021 | $494,000 | +32.8% | 3,050 | 0.0% | 0.30% | +8.5% |
| Q1 2021 | $372,000 | -20.3% | 3,050 | 0.0% | 0.27% | -41.5% |
| Q4 2020 | $467,000 | +46.9% | 3,050 | -19.7% | 0.46% | +31.0% |
| Q3 2020 | $318,000 | +14.0% | 3,800 | 0.0% | 0.36% | -30.9% |
| Q2 2020 | $279,000 | +20.8% | 3,800 | 0.0% | 0.51% | -26.4% |
| Q4 2019 | $231,000 | -45.4% | 3,800 | -47.2% | 0.70% | +120.9% |
| Q2 2018 | $423,000 | +14.3% | 7,200 | -11.1% | 0.32% | +12.1% |
| Q1 2018 | $370,000 | +94.7% | 8,100 | 0.0% | 0.28% | +107.4% |
| Q4 2017 | $190,000 | – | 8,100 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |